IMMUNOTHÉRAPIE DES CANCERS BRONCHIQUE NON À PETITES CELLULES UTILISANT DES LYMPHOCYTES T GÉNÉTIQUEMENT MODIFIÉS, SPÉCIFIQUES DE GD2

• 收藏
• 分享

专利权人:

Baylor College Of Medicine

发明人:

申请号：

EP11824106.6

公开号：

EP2614143B1

申请日:

2011.09.08

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention concerns immunotherapy for brain cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed, the chimeric receptor comprises antibody, cytoplasmic signaling domain from the T cell receptor, and costimulatory molecule(s).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/